Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jan 27, 2022; 14(1): 24-35
Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.24
Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.24
Table 1 Clinical, laboratory and operative patient characteristics (n = 83)
| Clinical, laboratory and operative patient characteristics (n = 83) | |
| Age (yr), median (IQR) | 59 (49–67) |
| Sex, male/female, n (%) | 36 (43)/47 (57) |
| Perioperative transfusion, n (%) | 21 (25) |
| Haemoglobin in g/L, median (IQR) | 115 (108–127) |
| Platelet count in 109/L, median (IQR) | 285 (243–372) |
| International Normalized Ratio, median (IQR) | 1.06 (1.01–1.15) |
| Serum glucose in mmol/L, median (IQR) | 5.1 (4.8–5.7) |
| Serum creatinine in mmol/L, median (IQR) | 53 (47–65) |
| Serum albumin in g/L, median (IQR) | 38.1 (32–41.1) |
| Serum total bilirubin in µmol/L, median (IQR) | 23.9 (12.9–60) |
| Serum CA 19-9 in IU/mL, median (IQR) | 26.3 (10–91.4) |
| Pancreaticoduodenectomy | |
| Pylorus-preserving PD, n (%) | 69 (83) |
| Whipple procedure, n (%) | 14 (17) |
Table 2 Histopathologic characteristics (n = 83)
| Histopathologic characteristics (n = 83) | |
| Tumour size in mm, median (IQR) | 27 (17–40) |
| Subtype, n (%) | |
| Intestinal | 57 (69) |
| Pancreatobiliary | 19 (23) |
| Others | 7 (8) |
| Tumour status, n (%) | |
| T1 | 7 (8) |
| T2 | 44 (53) |
| T3 | 32 (39) |
| Number of lymph nodes assessed, median (IQR) | 17 (12–24) |
| Lymph node status, n (%) | |
| N0 | 50 (60) |
| N1 | 22 (26) |
| N2 | 11 (14) |
| Differentiation, n (%) | |
| Well differentiated | 25 (30) |
| Moderately differentiated | 53 (64) |
| Poorly differentiated | 5 (6) |
| Lymphovascular invasion | 30 (36) |
| Perineural invasion | 26 (31) |
Table 3 Recurrence patterns after pancreaticoduodenectomy (n = 19)
| Organs involved | |||||
| Distant metastasis, n (%) | (A) First organ | (B) Second organ | (C) Third organ | A + B + C | % |
| Liver | 8 | 3 | 1 | 12 | 32 |
| Peritoneum | 4 | 3 | 1 | 8 | 22 |
| Lung | 4 | 2 | 1 | 7 | 19 |
| Supraclavicular lymph node | 1 | 1 | 3 | ||
| Bone | 1 | 1 | 3 | ||
| Suprarenal gland | 1 | 1 | 3 | ||
| Sub-table total | 30 | 81 | |||
| Lymph nodal recurrence, n (%) | |||||
| Celiac trunk | 1 | 1 | 3 | ||
| Hepatic hilum | 1 | 1 | 3 | ||
| Mesenteric lymph nodes | 1 | 1 | 2 | 5 | |
| Retroperitoneal lymph nodes | 2 | 1 | 3 | 8 | |
| Sub-table total | 7 | 19 | |||
| Total | 37 | 100 | |||
Table 4 Cox regression model analysis for predictors of overall survival
| Variables | Hazard ratio | 95%CI | P value | |
| Lower | Upper | |||
| Age in yr | 0.355 | |||
| Tumour size in mm | 1.03 | 1 | 1.06 | 0.059 |
| Histopathologic subtype | ||||
| Intestinal/other types | ||||
| Pancreatobiliary type | 2.7 | 1.2 | 6.2 | 0.025 |
| T classification | ||||
| T1-T2 | ||||
| T3 | 6.4 | 2.5 | 16.3 | < 0.001 |
| Lymph node metastasis | ||||
| No | ||||
| Yes | 4.5 | 1.8 | 11.3 | 0.001 |
| Differentiation grade | 0.54 | |||
| Well differentiated | ||||
| Moderately differentiated | 0.268 | |||
| Poorly differentiated | 0.755 | |||
| Perineural invasion | 0.517 | |||
| Lymphovascular invasion | 0.26 | |||
- Citation: Fernandez-Placencia RM, Montenegro P, Guerrero M, Serrano M, Ortega E, Bravo M, Huanca L, Bertani S, Trejo JM, Webb P, Malca-Vasquez J, Taxa L, Lachos-Davila A, Celis-Zapata J, Luque-Vasquez C, Payet E, Ruiz E, Berrospi F. Survival after curative pancreaticoduodenectomy for ampullary adenocarcinoma in a South American population: A retrospective cohort study. World J Gastrointest Surg 2022; 14(1): 24-35
- URL: https://www.wjgnet.com/1948-9366/full/v14/i1/24.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i1.24
